Cite
MLA Citation
Eugene Han et al.. “Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial.” Diabetes, obesity & metabolism, vol. 24, no. 4, 2022, pp. 752–756. http://access.bl.uk/ark:/81055/vdc_100152642146.0x000019